PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20208386-4	2010	Studies with HLM under-predict the ability of gemfibrozil and bupropion to cause clinically significant inhibition of CYP2C8 and CYP2D6, respectively, and over-predict the ability of ezetimibe to cause clinically significant inhibition of CYP3A4.	Gemfibrozil	46-57	cytochrome P450 family 2 subfamily D member 6	Homo sapiens	129-135	
20208386-5	2010	Gemfibrozil and bupropion represent examples of glucuronidation-dependent and reduction-dependent activation to metabolites that inhibit CYP2C8 and CYP2D6, respectively, whereas ezetimibe represents an example of glucuronidation-dependent protection against metabolism-dependent inhibition of CYP3A4.	Gemfibrozil	0-11	cytochrome P450 family 2 subfamily D member 6	Homo sapiens	148-154